retatrutide with cagrilintide vs CagriSema: The Battle Nobody's Covering RETATRUTIDE + CAGRILINTIDE – Research
Description
Persistent nausea, dizziness, or difficulty with your injection technique are also reasons to reach outyour provider may adjust your timing, dosage schedule, or provide additional training
Cost implications of proper vs improper storage Numbers tell the story better than generalities
The FDA hasn't approved it as safe or effective
The side effect profile matters
Storage of reconstituted peptide is recommended at 28C and should be used within 28 days of reconstitution
10.1056/NEJMcp1803290 92 RocksonS
